BDBM703965 (R)-5-amino-N-((5-bromopyridin- 2-yl)methyl)-6-methyl-N-(1- (pyrimidin-2-yl)ethyl)-1H- pyrrolo[3,2-b]pyridine-2- carboxamide LCMS [M + 1]+ = 468.0. 1H NMR (400 MHz, DMSO-d6) $#948; = 11.31 (br d, J = 3.2 Hz, 1H), 8.80 (br s, 3H), 8.12-7.86 (m, 1H), 7.54- 7.22 (m, 3H), 6.74-5.99 (m, 1H), 5.32 (br s, 2H), 5.12-4.30 (m, 1H), 2.13 (br s, 3H), 1.62 (br s, 2H), 1.23 (s, 3H)::US20240368153, Example 10-2
SMILES Cc1cc2[nH]c(C(=O)N(Cc3ccc(Br)cn3)[C@@H](C)c3ncccn3)cc2nc1N
InChI Key InChIKey=JKULQMNXTLIXNY-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 703965
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
Affinity DataIC50: 123nMAssay Description:Table B2: The assay uses recombinant full-length histone H2A as the PRMT5 substrate. Enzymatic transfer of the tritiated methyl group from S-adenosyl...More data for this Ligand-Target Pair
